Skip to main content
NeuronFeed
Home Investors Section 32

Section 32

Venture capital firm investing in technology, healthcare and frontier science.

Active VC 🇺🇸 United States · United States · Since 2017
Visit website
Portfolio Active
2
Latest Verge Genomics
Deal flow
$123M
2 rounds
Unicorns
0
≥ $1B valuation
Founded
2017
9 yrs
Latest
Jul 2022
Phaidra

About Section 32

Venture capital firm investing in technology, healthcare and frontier science.

Investment activity

2021–2022
$98M
$25M
1
'21
1
'22

Sector focus

🏢 AI Infrastructure 1
🏥 AI Healthcare 1
🤖 AI Agents 1

Geographic focus

US 2

Portfolio

2

Verge Genomics

We use human data and AI to develop better drugs faster

Phaidra

AI agents for AI factories, optimizing complex power, cooling, and workload management systems to maximize tokens per watt.

Co-investors

8

Character

1 shared

Mustafa Suleyman

1 shared

Helena

1 shared

Ahren Innovation Capital

1 shared

Flying Fish Partners

1 shared

Starshot Capital

1 shared

Lifeforce Capital

1 shared

Tao Capital Partners

1 shared

Recent rounds

2
Jul 1, 2022 Series A $25M Phaidra
Dec 1, 2021 Series B $98M Verge Genomics